Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ENHANCE Study (ElectroNic Hydroxyurea AdhereNCE): A Strategy to Improve Hydroxyurea Adherence in Patients With Sickle Cell Disease

NCT02578017 is registered in ClinicalTrials.gov with Nationwide Children's Hospital as lead sponsor.

NCT NCT02578017
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02578017 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ENHANCE Study (ElectroNic Hydroxyurea AdhereNCE): A Strategy to Improve Hydroxyurea Adherence in Patients With Sickle Cell Disease
Lead sponsor
Nationwide Children's Hospital
Phase
Not applicable
Overall status
Completed
Start date
July 31, 2014
Completion date
June 30, 2019
Enrollment
71 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sickle cell disease